Contribution: Industrial Research Assistance Program – Contributions to Firms
DMF Medical Incorporated
$465,526.00
ICU Ventilation Add-on Device
FY 2021-22 · 2021-07-12
Summary
Recognizing trends toward volatile anaesthetic use in ICU, DMF’s core memsorb™ technology will be used to develop a modular add-on device for existing ICU ventilators to enhance clinical outcomes and improve environmental footprint in perioperative ICU volatile sedation.
Department
Program
Industrial Research Assistance Program – Contributions to FirmsIndustrial Research Assistance Program-Contributions to Firms (linked with high confidence)
Recipient
Location
Dartmouth|Dartmouth, Nova Scotia, Canada
Recipient Type
For-profit organization
Business Number
809537517
Type
Contribution
Source
Proactive Disclosure - Grants and Contributions
Amendments
Each version of the agreement as published, oldest first, with its total as of that version. The amount above is the latest.
| Amendment | Date | Fiscal Year | Total |
|---|---|---|---|
| 0 | 2021-07-12 | 2021-22 | $323,733.00 |
| 1 | 2021-07-12 | 2021-22 | $465,526.00 |
As published
Additional Information
This agreement has been amended 1 time(s). The end date of this agreements has been modified by 214 days. The total amended value is 141,793 dollars.
Additional Information (French)
Cet accord a été modifié 1 fois La date de fin du présent accord a été changé de 214 jours. La valeur totale des modifications est de 141 793 dollars.
Agreement End Date
2023-09-30
Agreement Number
975391
Agreement Start Date
2021-07-12
Agreement Title
ICU Ventilation Add-on Device
Agreement Title (French)
Dispositif d'appoint pour les ventilateurs des soins intensifs
Agreement Type
Contribution
Agreement Value
$465,526.00
Amendment Date
2022-10-03
Amendment Number
1
Coverage
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation. | Les projets des Contributions aux entreprises stimulent la création de richesse au Canada grâce à l’innovation technologique.
Description
Recognizing trends toward volatile anaesthetic use in ICU, DMF’s core memsorb™ technology will be used to develop a modular add-on device for existing ICU ventilators to enhance clinical outcomes and improve environmental footprint in perioperative ICU volatile sedation.
Description (French)
Reconnaissant la tendance à l'utilisation d'anesthésiques volatils dans les unités de soins intensifs, la technologie de base memsorb™ de DMF sera utilisée pour concevoir un dispositif modulaire complémentaire pour les ventilateurs existants des unités de soins intensifs. Ce dispositif permettra d'améliorer les résultats cliniques et l'empreinte environnementale de la sédation volatile dans les unités de soins intensifs périopératoires.
Expected Results
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Expected Results (French)
Le PARI, par le biais des Contributions aux entreprises, vise à appuyer la recherche, le développement, l’adaptation et/ou l’adoption au Canada de produits, de services ou de processus novateurs ou axés sur des technologies nouvelles ou améliorées, et ce jusqu’à leur commercialisation
Federal Riding
Dartmouth--Cole Harbour
Federal Riding (French)
Dartmouth--Cole Harbour
Federal Riding Number
12004
NAICS Code
339110
Organization Code
nrc-cnrc
Organization
National Research Council Canada | Conseil national de recherches Canada
Program Name
Industrial Research Assistance Program – Contributions to Firms
Program Name (French)
Programme d’aide à la recherche industrielle – Contributions aux entreprises
Program Purpose
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Program Purpose (French)
Le PARI, par le biais des Contributions aux entreprises, vise à appuyer la recherche, le développement, l’adaptation et/ou l’adoption au Canada de produits, de services ou de processus novateurs ou axés sur des technologies nouvelles ou améliorées, et ce jusqu’à leur commercialisation
Recipient Business Number
809537517
Recipient City
Dartmouth|Dartmouth
Recipient Country
CA
Recipient Legal Name
DMF Medical Incorporated
Recipient Postal Code
B2Y 4M9
Recipient Province or Territory
NS
Recipient Type
F
Reference Number
172-2021-2022-Q2-975391
